View in EDS HTML Full Text PDF Full Text

Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na+ /H+ exchanger-1 inhibition.

Saved in:
Bibliographic Details
Title: Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na+ /H+ exchanger-1 inhibition.
Authors: Liu X; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Qiu Y; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Huang N; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Liu YH; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Wang HH; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Yu YN; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Song YT; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Wan GR; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Wang SX; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Li P; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Yin YL; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Source: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2022 Mar; Vol. 36 (3), pp. e22971. Date of Electronic Publication: 2021 Nov 23.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0461 (Electronic) Linking ISSN: 10956670 NLM ISO Abbreviation: J Biochem Mol Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34813134
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na<superscript>+</superscript> /H<superscript>+</superscript> exchanger-1 inhibition.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Qiu+Y%22">Qiu Y</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Huang+N%22">Huang N</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Liu+YH%22">Liu YH</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Wang+HH%22">Wang HH</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Yu+YN%22">Yu YN</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Song+YT%22">Song YT</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Wan+GR%22">Wan GR</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Wang+SX%22">Wang SX</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Li+P%22">Li P</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Yin+YL%22">Yin YL</searchLink>; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229717231%22">Journal of biochemical and molecular toxicology</searchLink> [J Biochem Mol Toxicol] 2022 Mar; Vol. 36 (3), pp. e22971. <i>Date of Electronic Publication: </i>2021 Nov 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9717231 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1099-0461 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210956670%22">10956670 </searchLink><i>NLM ISO Abbreviation: </i>J Biochem Mol Toxicol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34813134
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jbt.22971
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e22971
    Titles:
      – TitleFull: Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na+ /H+ exchanger-1 inhibition.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Qiu Y
      – PersonEntity:
          Name:
            NameFull: Huang N
      – PersonEntity:
          Name:
            NameFull: Liu YH
      – PersonEntity:
          Name:
            NameFull: Wang HH
      – PersonEntity:
          Name:
            NameFull: Yu YN
      – PersonEntity:
          Name:
            NameFull: Song YT
      – PersonEntity:
          Name:
            NameFull: Wan GR
      – PersonEntity:
          Name:
            NameFull: Wang SX
      – PersonEntity:
          Name:
            NameFull: Li P
      – PersonEntity:
          Name:
            NameFull: Yin YL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2022 Mar
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1099-0461
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of biochemical and molecular toxicology
              Type: main
ResultId 1